abstract |
N-biarylmethylaminocycloalkanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists which can be used in the treatment or prophylaxis of such symptoms as pain and inflammation associated with the bradykinin B1 metabolic chain of reaction. |